Mesalamine to Reduce T Cell Activation in HIV Infection
This study is enrolling participants by invitation only.
Sponsor:
University of California, San Francisco
Collaborators:
California HIV/AIDS Research Program
Salix Pharmaceuticals
Information provided by (Responsible Party):
Ma Somsouk, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01090102
First received: March 17, 2010
Last updated: November 8, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |